Content area

|
|

Menoragi under antikoagulansbehandling

Forfatter(e)

Maja Hellfritzsch1, 2, Anne-Mette Hvas3, 4, Margit Dueholm5, Erik Lerkevang Grove4, 6 & Morten Würtz2, 6

1) Klinisk Farmakologisk Afdeling, Aarhus Universitetshospital, 2) Hjertesygdomme, Hospitalsenheden Vest, Herning, 3) Blodprøver og Biokemi, Aarhus Universitetshospital, 4) Institut for Klinisk Medicin, Aarhus Universitet, 5) Kvindesygdomme og Fødsler, Aarhus Universitetshospital, 6) Hjertesygdomme, Aarhus Universitetshospital

Ugeskr Læger 2020;182:V08200614

Reference: 
Ugeskr Læger 2020;182:V08200614
Blad nummer: 
Menorrhagia during oral anticoagulant therapy

Maja Hellfritzsch, Anne-Mette Hvas, Margit Dueholm, Erik Lerkevang Grove & Morten Würtz

Ugeskr Læger 2020;182:V08200614

Menorrhagia is a common complication to oral anticoagulant therapy in premenopausal women. Clinical management of menorrhagia poses a clinical dilemma with the need of weighting bleeding risk against the risk of recurrent thrombosis. In this review, we describe the risk of menorrhagia during oral anticoagulant therapy, with emphasis on the differences between the specific anticoagulant drugs. We critically assess the treatment options for anticoagulant-associated menorrhagia, and we provide a treatment algorithm for the management of anticoagulant-associated menorrhagia.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Jacob Peter Philipsen | 03/05
2 kommentarer
af Nils Thorm Milman | 03/05
1 Kommentar
af Thora Gudrunardottir | 01/05
1 Kommentar
af Wojciech Zbigniew Pawlak | 01/05
2 kommentarer
af Gina Al-Farra | 29/04
1 Kommentar
af Birgitte Rode Diness | 29/04
4 kommentarer